You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | 0.0% | n/a |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -8.0 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 0.0 | 0.0 |
| Price / Book value | -85.4 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 28.9% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (€m) |
Pre-tax (€m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | n/a | -21.06 | €-0.76 | -11.8 | 0.0 | n/a | n/a | 0.0% |
| 2018-12-31 | 0.02 | -20.08 | €-0.65 | -0.9 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | n/a | -13.25 | €-0.36 | -8.6 | 0.0 | n/a | n/a | 0.0% |
| 2020-12-31 | n/a | -16.94 | €-0.37 | -7.9 | 0.0 | n/a | n/a | 0.0% |
| Marie-Louise Fjallskog tapped as Faron's new chief medical officer Sharecast News | 04 Jan |
|---|---|
| Faron Pharmaceuticals wins dispute with Rentschler at tribunal Sharecast News | 09 Nov |
| Faron doses first patient in Covid-19 treatment trial Sharecast News | 25 Aug |
| Grant of options | 28-Jan-22 07:00 |
|---|---|
| Faron at Proactive One2One Investor Forum | 24-Jan-22 07:00 |
| Faron to Present at Redeye Fight Cancer Seminar | 17-Jan-22 07:00 |
| Faron to Present at H.C. Wainwright BioConnect | 05-Jan-22 07:00 |
| Faron Appoints Marie-Louise Fjällskog as CMO | 04-Jan-22 07:00 |